Table 3.
Sex, age, concentration of selected inflammatory markers as well as the distribution profile of glycosylated acute phase proteins for study population subgroups.
| Group: age | 12–14 | 15–18 | ||||||
|---|---|---|---|---|---|---|---|---|
| Sex | Female | Male | Female | Male | ||||
| Percentile of BMI | 90–97% | >97% | 90–97% | >97% | 90–97% | >97% | 90–97% | >97% |
| IL-6 (pg/L) | 1.2 | 1.1 | 1.8 | 1.7 | 2.2 | 2.3 | 1.7 | 1.3 |
| AGP (mg/L) | 1108±321 | 908±250 | 1578±327 | 940±250 | 930±223 | 1333±281 | 904±238 | 896±260 |
| W0 (%) | 44 | 44 | 46 | 41 | 43 | 39 | 41 | 38 |
| W1 (%) | 43 | 44 | 40 | 43 | 39 | 43 | 44 | 43 |
| W2 (%) | 12 | 10 | 13 | 13 | 15 | 15 | 12 | 16 |
| W3 (%) | 1 | 1 | 1 | 3 | 2 | 2 | 2 | 3 |
| ACT (mg/L) | 382±174 | 373±97 | 504±139 | 328±100 | 371±136 | 515±187 | 494±130 | 468±118 |
| A1 (%) | 26 | 28 | 18 | 30 | 24 | 26 | 24 | 23 |
| A2 (%) | 31 | 33 | 26 | 32 | 40 | 30 | 31 | 30 |
| A3 (%) | 22 | 21 | 26 | 23 | 20 | 23 | 26 | 23 |
| A4 (%) | 13 | 10 | 23 | 10 | 13 | 16* | 13 | 18 |
| A5 (%) | 8 | 7 | 7 | 4 | 2 | 5 | 5 | 5 |